{"DataElement":{"publicId":"7771584","version":"1","preferredName":"Treatment Cohort Study 10507 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10507 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_10507_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7771580","version":"1","preferredName":"10507 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"7771580v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SG4","valueDescription":"SG4: Phase 2 Dose expansion","ValueMeaning":{"publicId":"7771581","version":"1","preferredName":"SG4: Phase 2 Dose expansion","longName":"7771581","preferredDefinition":"SG4: Phase 2 Dose expansion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA89E28D-99D8-1C1B-E053-4EBD850A7F3D","latestVersionIndicator":"Yes","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"ONEDATA","dateModified":"2021-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA89E28D-99F1-1C1B-E053-4EBD850A7F3D","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"ONEDATA","dateModified":"2021-08-27","deletedIndicator":"No"},{"value":"SG3","valueDescription":"SG3: Phase 2","ValueMeaning":{"publicId":"7771582","version":"1","preferredName":"SG3: Phase 2","longName":"7771582","preferredDefinition":"SG3: Phase 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA89E28D-99FB-1C1B-E053-4EBD850A7F3D","latestVersionIndicator":"Yes","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"ONEDATA","dateModified":"2021-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA89E28D-9A14-1C1B-E053-4EBD850A7F3D","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"ONEDATA","dateModified":"2021-08-27","deletedIndicator":"No"},{"value":"SG2","valueDescription":"SG2: Non-Thoracic, Non-BRD4 Exploratory Cohort","ValueMeaning":{"publicId":"7771583","version":"1","preferredName":"SG2: Non-Thoracic, Non-BRD4 Exploratory Cohort","longName":"7771583","preferredDefinition":"SG2: Non-Thoracic, Non-BRD4 Exploratory Cohort","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA89E28D-9A1E-1C1B-E053-4EBD850A7F3D","latestVersionIndicator":"Yes","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"ONEDATA","dateModified":"2021-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA89E28D-9A37-1C1B-E053-4EBD850A7F3D","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"ONEDATA","dateModified":"2021-08-27","deletedIndicator":"No"},{"value":"SG1","valueDescription":"SG1: Phase 1 Dose Escalation","ValueMeaning":{"publicId":"6676370","version":"1","preferredName":"SG1: Phase 1 Dose Escalation","longName":"6676370","preferredDefinition":"SG1: Phase 1 Dose Escalation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"845F1CF0-B35A-2BB9-E053-F662850AEB9B","latestVersionIndicator":"Yes","beginDate":"2019-03-18","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-03-18","modifiedBy":"ONEDATA","dateModified":"2019-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA89E28D-9A41-1C1B-E053-4EBD850A7F3D","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"ONEDATA","dateModified":"2021-08-27","deletedIndicator":"No"},{"value":"SG5","valueDescription":null,"ValueMeaning":{"publicId":"10176631","version":"1","preferredName":"SG5: Phase 1 Dose Expansion","longName":"10176631v1.00","preferredDefinition":"SG5: Phase 1 Dose Expansion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED59C7C-DA7E-2C7E-E053-731AD00A16FD","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-05-12","modifiedBy":"SOKKERL","dateModified":"2022-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED59C7C-DA7F-2C7E-E053-731AD00A16FD","beginDate":"2022-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-05-12","modifiedBy":"SOKKERL","dateModified":"2022-05-12","deletedIndicator":"No"},{"value":"DL-1","valueDescription":null,"ValueMeaning":{"publicId":"14175973","version":"1","preferredName":"DL-1: ZEN003694 36mg + etoposide + CISplatin","longName":"14175973v1.00","preferredDefinition":"DL-1: ZEN003694 36mg + etoposide + CISplatin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0163EFF9-6F4A-74E9-E063-731AD00AA9D7","latestVersionIndicator":"Yes","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0163EFF9-6F4F-74E9-E063-731AD00AA9D7","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","deletedIndicator":"No"},{"value":"DL-2","valueDescription":null,"ValueMeaning":{"publicId":"14175974","version":"1","preferredName":"DL-2: ZEN003694 24mg + etoposide + CISplatin","longName":"14175974v1.00","preferredDefinition":"DL-2: ZEN003694 24mg + etoposide + CISplatin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0163EFF9-6F4B-74E9-E063-731AD00AA9D7","latestVersionIndicator":"Yes","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0163EFF9-6F50-74E9-E063-731AD00AA9D7","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","deletedIndicator":"No"},{"value":"DL1","valueDescription":null,"ValueMeaning":{"publicId":"14175975","version":"1","preferredName":"DL1: ZEN003694 48mg + etoposide + CISplatin","longName":"14175975v1.00","preferredDefinition":"DL1: ZEN003694 48mg + etoposide + CISplatin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0163EFF9-6F4C-74E9-E063-731AD00AA9D7","latestVersionIndicator":"Yes","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0163EFF9-6F51-74E9-E063-731AD00AA9D7","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","deletedIndicator":"No"},{"value":"DL2","valueDescription":null,"ValueMeaning":{"publicId":"14175976","version":"1","preferredName":"DL2: ZEN003694 60mg + etoposide + CISplatin","longName":"14175976v1.00","preferredDefinition":"DL2: ZEN003694 60mg + etoposide + CISplatin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0163EFF9-6F4D-74E9-E063-731AD00AA9D7","latestVersionIndicator":"Yes","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0163EFF9-6F52-74E9-E063-731AD00AA9D7","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","deletedIndicator":"No"},{"value":"TAC1","valueDescription":null,"ValueMeaning":{"publicId":"14175977","version":"1","preferredName":"TAC1: ZEN003694 60mg","longName":"14175977v1.00","preferredDefinition":"TAC1: ZEN003694 60mg","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0163EFF9-6F4E-74E9-E063-731AD00AA9D7","latestVersionIndicator":"Yes","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0163EFF9-6F53-74E9-E063-731AD00AA9D7","beginDate":"2023-07-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-07-26","modifiedBy":"SOKKERL","dateModified":"2023-07-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA89E28D-99C0-1C1B-E053-4EBD850A7F3D","latestVersionIndicator":"Yes","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"SOKKERL","dateModified":"2023-07-26","changeDescription":"Curated for Protocol 10507 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Patient subgroup","type":"Preferred Question Text","description":"Patient subgroup","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Please select the cohort","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA89E28D-9A4B-1C1B-E053-4EBD850A7F3D","latestVersionIndicator":"Yes","beginDate":"2021-08-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-08-27","modifiedBy":"SOKKERL","dateModified":"2023-07-26","changeDescription":"curated for prot10507 ls 8/27/21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}